Press Releases Latest May 02, 2024 Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting Press Releases Year None202420232022202120202019201820172016201520142013 Aug 28, 2018 THERATECHNOLOGIES FILES MARKETING AUTHORIZATION APPLICATION FOR TROGARZO™ IN EUROPE Aug 20, 2018 EUROPEAN MEDICINES AGENCY AUTHORIZES DEFERRAL OF PAEDIATRIC INVESTIGATION PLAN FOR TROGARZO™ Aug 15, 2018 THE NEW ENGLAND JOURNAL OF MEDICINE PUBLISHES TWO ARTICLES ON TROGARZO™ Jul 31, 2018 European Medicines Agency Confirms Accelerated Assessment Procedure for Trogarzo™ Jul 25, 2018 TROGARZO™ INCLUDED IN MOST RECENT TREATMENT GUIDELINES ISSUED BY INTERNATIONAL ANTIVIRAL SOCIETY Jul 05, 2018 Theratechnologies Announces Financial Results for the Second Quarter of 2018 Jul 04, 2018 Theratechnologies Submits Novel Single-Vial Formulation of EGRIFTA® (Tesamorelin for Injection) for FDA Approval Jun 28, 2018 Theratechnologies to Announce Financial Results for Second Quarter 2018 Jun 19, 2018 TH Announces Closing of US$57.5 Million Bought Deal Offering Of 5.75% Convertible Unsecured Senior Notes May 30, 2018 TH and EMD Serono Agree on Early and Final Payment First page « Previous page ‹ … Page 20 Page 21 Page 22 Page 23 Current page 24 Page 25 Page 26 Page 27 Page 28 … Next page › Last page » Displaying 231 - 240 of 361
May 02, 2024 Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting
Aug 20, 2018 EUROPEAN MEDICINES AGENCY AUTHORIZES DEFERRAL OF PAEDIATRIC INVESTIGATION PLAN FOR TROGARZO™
Jul 25, 2018 TROGARZO™ INCLUDED IN MOST RECENT TREATMENT GUIDELINES ISSUED BY INTERNATIONAL ANTIVIRAL SOCIETY
Jul 04, 2018 Theratechnologies Submits Novel Single-Vial Formulation of EGRIFTA® (Tesamorelin for Injection) for FDA Approval
Jun 19, 2018 TH Announces Closing of US$57.5 Million Bought Deal Offering Of 5.75% Convertible Unsecured Senior Notes